Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06808048 · ClinicalTrials.gov registry record · NA
Medical Cannabis and Behavior
A NA study of Chronic Pain Patients and Medical Cannabis Users, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT06808048: Recruiting NA study of Chronic Pain Patients and Medical Cannabis Users, sponsored by University of Minnesota.
NCT06808048 is a NA study of Chronic Pain Patients and Medical Cannabis Users that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06808048, a NA study of Chronic Pain Patients and Medical Cannabis Users, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess cognition, neural function, and drug exposure in chronic pain patients who have been prescribed medical cannabis and will differentiate outcomes based on use of specific CBD-dominant versus THC-dominant treatment products. This longitudinal study will recruit medical cannabis users from local dispensaries. Each participant will complete a baseline assessment prior to the start of medical cannabis use, monthly phone calls to assess treatment adherence, and a four-month follow- up assessment. The aims of this project are: Aim 1. To assess impacts of medical cannabis compounds on executive functions, learning and memory in adults to determine whether cognitive impairments are evident after the onset of cannabis use; Aim 2. To assess the impacts of medical cannabis compounds on white matter microstructure, functional brain activity and functional connectivity; Aim 3. To differentiate change over four months in these outcomes as a function of (a) age and (b) pre-to-post-treatment changes in blood levels of cannabinoid compounds.
Primary Outcome
All participants will complete a cognitive task battery measuring processes such as learning and memory. The Rey Auditory Verbal Learning Test requires individuals to learn a list of words across five learning trials followed by a distractor list then immediate recall of the initial word list then a 30-minute delayed recall. The minimum score on each trial is 0 and the maximum score on each trial is 15. Scores are tabulated for each of the eight trials. Scores on trials 1-5 reflect learning. Sco
Conditions Studied
Interventions
- BEHAVIORAL Cognitive testing
- BEHAVIORAL Task-based fMRI measure of inhibitory control
- BEHAVIORAL Task-based fMRI measure of face-name learning
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-06-18 |
| Est. Completion | 2029-07-31 |
| Phase | NA |
What NCT06808048 shows while recruiting
NCT06808048 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Chronic Pain Patients appearing as the primary indexed condition, and to 3 interventions - of which Cognitive testing is the first listed.
NCT06808048 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06808048 about?
NCT06808048 is a clinical study titled "Medical Cannabis and Behavior". This study will assess cognition, neural function, and drug exposure in chronic pain patients who have been prescribed medical cannabis and will differentiate outcomes based on use of specific CBD-dominant versus THC-dominant treatment products. This longitudinal study will recruit medical cannabis ...
What is the current status of trial NCT06808048?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-06-18. Estimated completion is 2029-07-31.
What conditions does trial NCT06808048 study?
This clinical trial studies the following conditions: Chronic Pain Patients, Medical Cannabis Users.
What interventions are being tested in trial NCT06808048?
The interventions under investigation include: Cognitive testing (BEHAVIORAL), Task-based fMRI measure of inhibitory control (BEHAVIORAL), Task-based fMRI measure of face-name learning (BEHAVIORAL).
Who is sponsoring clinical trial NCT06808048?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06808048 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06808048's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI